SKI Market

Indian Indices

Sensex

82,921.38 -324.80
( -0.39%)

Global Indices

Nasdaq

49,380.33 -83.12
(-0.17%)

Dow Jones

6,961.01 -4.46
(-0.06%)

Hang Seng

53,565.61 -370.56
(-0.69%)

Nikkei 225

10,200.95 -34.34
(-0.34%)

Forex

USD-INR

90.54 0.22
(0.24%)

EUR-INR

105.01 0.03
(0.03%)

GBP-INR

121.08 -0.01
(-0.01%)

JPY-INR

0.57 0.00
(0.52%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

330.3875196

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

35.34

33582.07

EPS(TTM)

Face Value()

Div & Yield %

76.07

1.05

Back

KSB standalone net profit rises 9.61% in the September 2025 quarter

Nov 12,2025

Net profit of KSB rose 9.61% to Rs 65.00 crore in the quarter ended September 2025 as against Rs 59.30 crore during the previous quarter ended September 2024. Sales rose 5.35% to Rs 649.50 crore in the quarter ended September 2025 as against Rs 616.50 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	649.50	616.50	5
OPM %	13.04	14.21	-
PBDT	102.50	93.60	10
PBT	87.80	79.90	10
NP	65.00	59.30	10

82,921.38 -324.80 ( -0.39%)

49,380.33 -83.12 (-0.17%)

6,961.01 -4.46 (-0.06%)

53,565.61 -370.56 (-0.69%)

10,200.95 -34.34 (-0.34%)

90.54 0.22 (0.24%)

105.01 0.03 (0.03%)

121.08 -0.01 (-0.01%)

0.57 0.00 (0.52%)